ProCE Banner Activity

Systemic Therapy Combinations for Early- and Intermediate-Stage HCC: Current Evidence and Ongoing Trials

Slideset

Download this slideset from a live symposium at ASCO 2023 to review expert perspectives on emerging immunotherapy combinations for treating patients with early- and intermediate-stage HCC.

Released: June 02, 2023

Share

Faculty

Thomas A. Abrams

Thomas A. Abrams, MD

Institute Physician
Director, Liver Tumor Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

Provided by the National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational from AstraZeneca.

AstraZeneca

Partners

Clinical Care Options, LLC

ProCE Banner